Cambrian BioPharma Inc - Insider Non-Derivative Transactions at Sensei Biotherapeutics, Inc. (SNSE) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 9, 2025, Cambrian BioPharma Inc's relationship to Sensei Biotherapeutics, Inc. (SNSE) is TenPercentOwner, and currently has 5,235,956 shares of Restricted Stock Unit Grant, and 158,254 shares of Common Stock.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SNSE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Cambrian BioPharma Inc - Insider Non-Derivative Transactions of SNSE Restricted Stock Unit Grant

Cambrian BioPharma Inc - Insider Non-Derivative Transactions of SNSE Common Stock

Cambrian BioPharma Inc - Insider Non-Derivative Transactions at SNSE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 10, 2025	Sell -- (Common Stock)	446	7.92	155142
Dec 10, 2025	Sell -- (Common Stock)	395	8.04	155588
Dec 10, 2025	Sell -- (Common Stock)	2666	7.95	155588
Dec 10, 2025	M -- (Common Stock)	395	6.4	155983
Dec 10, 2025	Sell -- (Common Stock)	3105	8.59	158254
Dec 6, 2025	Sell -- (Common Stock)	42	13.16	161359
Dec 6, 2025	Sell -- (Common Stock)	1745	12.29	161401
Dec 6, 2025	Sell -- (Common Stock)	14508	11.4	163146
Dec 5, 2025	Sell -- (Common Stock)	5000	9.06	177654
Aug 1, 2023	Disposition -- (Common Stock)	1587302	1.26	3653120
Jul 11, 2023	Acquisition -- (Common Stock)	4466	0	5240422
Jun 11, 2022	Acquisition -- (Restricted Stock Unit Grant)	4466	0	5235956